Table 3.
In vivo animal research of the 15 medicine food homology plants.
Botanical name∗ | Model | Dose | Route | Intervention time | Main improved results | Reference |
---|---|---|---|---|---|---|
Portulaca oleracea | The extract in LPS-induced osteolysis male mice. | 250 mg/kg | Administered orally | Every 2 days for 8 days | Bone loss, bone erosion, and the number of TRAP-positive osteoclasts↓ | [13] |
BV/TV, Tb.Sp, and Tb.N↑ | ||||||
| ||||||
Houttuynia cordata | The essential oil in OVX mice. | 10 and 20 mg/kg | I.g. | 12 weeks | ALP, TRAP, TNF-α, IL-1β, and MDA↓ | [39] |
SOD, parameters of bone morphometry , and biomechanical properties↑ | ||||||
| ||||||
Prunella vulgaris | The flavonoids in OVX rats. | 10% | I.g. | 12 weeks | ALP, the number of osteoclasts, and bone resorption perimeter percentage↓ | [40] |
OPG, BMD, and the relative volume and thickness of trabecular bone↑ | ||||||
| ||||||
Hovenia acerba | (1) The extract in normal 8-week-old male mice. | 200 mg/kg | I.p. | 5 sequential days each week for 4 weeks | Trabecular bone, BV/TV and Tb.N, femoral bone mass, and thickness and area of femoral cortical bone↑ | [18] |
Trabecular or cortical femoral bone loss↓ | ||||||
(2) Methyl vanillate in OVX mice. | Administrated orally | 5 sequential days each week for 4 weeks | BV/TV, Tb.N, trabecular bone volume↑ | |||
| ||||||
Cichorium intybus | (1) Chicory inulins and a mixture of inulins-isoflavones in OVX rats. | 385 mg/day | In water | 2 months | BMD↑ | [41] |
(2) Chicory inulin in growing male rats. | 5 and 10 g/100 g diet | In diet | 22 weeks | WBBMC and WBBMD↑ | [42] | |
(3) A purified native inulin, a reformulated inulin, and a dehydrated chicory in young male rats. | 7.5% inulin in the diet | In diet | 3 months | Mg absorption, BMD, and breaking load↑ | [43] | |
(4) The chicory extracts in GIOP rats. | 100 mg/kg | Administrated orally | 3 times per week for 8 weeks | Ca, P, BMD, BMC↑ | [44] | |
PTH, ALP↓ | ||||||
| ||||||
Panax ginseng | (1) Ginseng on osteoporosis in OVX rats in which inflammation was induced. | 100 and 200 mg/kg | Administrated orally | 20 days | BMD↑ | [45] |
OC, TNF-α, IL-1β, IL-6↓ | ||||||
(2) Ginsenoside Rg3 in OVX rats | 20 mg/kg | I.p. | Every 2 days for 5 weeks | Thickness, number, and density of trabeculae, osteogenesis↑ | [19] | |
(3) Ginseng extracts in 112-week-old male rats. | 300 mg/kg/day | Administrated orally | 8 weeks | Total BMD in the tibia,osteoblast↑ | [46] | |
| ||||||
Morus alba | The extract in OVX rats. | 0.5% or 1% | Tube feeding | 8 weeks | ALP, fragile structure was reduced↓ | [47] |
Trabecular thickness↑ | ||||||
| ||||||
Polygonatum sibiricum | (1) The polysaccharide in OVX rats. | 100, 200, and 400 mg/kg | I.g. | Every 2 days for 35 days | BMD, BGP↑ | [48] |
ALP, TRAP, and TNF-α↓ | ||||||
(2) The polysaccharide on osteoporotic fracture, which is established by OVX rats. | 100, 500, and 1000 mg/kg | I.g. | 8 weeks | TRAP and PINP↓ | [49] | |
ALP, OPG, the maximum tibial load, elastic load, BMD, BGP, GPR48, and BMP-2 protein↑ | ||||||
| ||||||
Lycium barbarum | The extract in OVX mice. | 1 and 100 mg/kg | Administrated orally | 6 weeks. | BMC, BMD, CON, calcium↑ | [50] |
Hypertrophy of the epiphyseal plate ↓ | ||||||
| ||||||
Eugenia caryophyllata | The extract in OVX rats. | Administrated orally | 4 weeks | AP, TRAP, urinary phosphate, and creatinine↓ | [51] | |
Ca, bone density, bone mineral content, bone tensile strength↑ | ||||||
| ||||||
Alpinia officinarum | The extract in OVX rats. | 300 mg/kg | I.g. | 12 weeks | OP↓ | [30] |
Bone strength↑ | ||||||
| ||||||
Crocus sativus | (1) Crocin in OVX rats. | 5, 10, and 20 mg/kg | Administrated orally | 16 weeks | BMD of L4 vertebrae and femurs, skeletal remodeling, bone-turnover markers↑ | [52] |
Oxidative stress status in bone tissue↓ | ||||||
(2) Crocin in metabolic syndrome-induced osteoporosis rats. | 5 and 10 mg/kg | I.g. | 5 sequential days each week for 12 weeks | OCN, longitudinal, and perpendicular forces of femurs↑ | [53] | |
TRAP, CTX1, IL-6, TNF-α, oxidative stress in femur distal epiphysis tissues↓ | ||||||
| ||||||
Morus alba | The combined extract of mulberry leaf and Polygonum odoratum in OVX rats. | 5, 150, and 300 mg/kg | Administrated orally | 3 months | Oxidative stress and osteoclast density↓ | [54] |
Osteoblast density and cortical thickness, serum Ca, ALP, and OCN↑ | ||||||
| ||||||
Chrysanthemum morifolium | Linarin in OVX mice | 50 and 150 mg/kg | I.g. | 8 weeks | BMD, BV/TV, BS/TV, and Tb.N↑ | [32] |
ALP and OCN↓ | ||||||
| ||||||
Coix lacryma-jobi | (1) The adlay diet and adlay extract in OVX mice. | 10% and 30% in diet | In diet | 4 weeks | ALP, Ca, and BMD↑ | [37] |
(2) The extract in OVX rats. | 300 μg/mL | Administrated orally | 4 weeks | ALP, Ca↑ | [38] | |
TRAP↓ |
Notes. ∗Botanical name are according to Chinese Pharmacopoeia (Chinese Pharmacopoeia Commission, China Medical Science Press, Beijing, China, 2020). Abbreviations: ALP, alkaline phosphatase; BMD, bone mineral density; BGP, bone Gla protein; BMP-2, bone morphogenetic protein-2; BV/TV, bone volume/total volume; CTXI; collagen cross-linking carboxy-terminal telopeptide, type I; GIOP, glucocorticoid-induced osteoporosis; GPR48, G protein-coupled receptor 48; IL-1β, interleukin-1β; LPS, lipopolysaccharide; MDA, malondialdehyde; OCN, osteocalcin; OP, osteopontin; OPG, osteoprotegerin; OVX, ovariectomy; PINP, procollagen type I N-terminal propeptide; PTH, parathyroid hormone; SOD, superoxide dismutase; Tb.N, trabecular number; Tb.Sp, trabecular separation; TNF-α, tumor necrosis factor-α; TRAP, tartrate-resistant acid phosphatase; WBBMC, whole-body bone mineral content; WBBMD, whole-body bone mineral density.